TreeWAS – Variant ID: rs12265836

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C34.0 Main bronchus	0.000	0.879	0.121
C34 Malignant neoplasm of bronchus and lung	0.000	0.880	0.120
C34.3 Lower lobe, bronchus or lung	0.000	0.882	0.118
C34.9 Bronchus or lung, unspecified	0.000	0.894	0.106
C34.1 Upper lobe, bronchus or lung	0.000	0.894	0.106
C34.8 Overlapping lesion of bronchus and lung	0.000	0.914	0.086
T46 Poisoning by agents primarily affecting the cardiovascular system	0.080	0.920	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.078	0.922	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.077	0.923	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.076	0.924	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.075	0.925	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.074	0.926	0.000
C34.2 Middle lobe, bronchus or lung	0.000	0.926	0.074
T42.4 Benzodiazepines	0.071	0.929	0.000
T42.1 Iminostilbenes	0.071	0.929	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.069	0.931	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.069	0.931	0.000
T46.1 Calcium-channel blockers	0.066	0.933	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.066	0.934	0.000
T39.0 Salicylates	0.066	0.934	0.000
T39.1 4-Aminophenol derivatives	0.065	0.935	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.064	0.936	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.062	0.937	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.062	0.938	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.060	0.940	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.058	0.942	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.057	0.942	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.057	0.942	0.000
T46.7 Peripheral vasodilators	0.057	0.942	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.057	0.942	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.057	0.942	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.056	0.944	0.000
T36 Poisoning by systemic antibiotics	0.056	0.944	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.055	0.945	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.055	0.945	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.055	0.945	0.000
T39.4 Antirheumatics, not elsewhere classified	0.055	0.945	0.000
T39.2 Pyrazolone derivatives	0.055	0.945	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.054	0.946	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.054	0.946	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.054	0.946	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.054	0.946	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.054	0.946	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.054	0.946	0.000
T44.0 Anticholinesterase agents	0.054	0.946	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.053	0.946	0.000
T42.3 Barbiturates	0.053	0.946	0.000
T42.2 Succinimides and oxazolidinediones	0.053	0.946	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.053	0.947	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.053	0.947	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.053	0.947	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.053	0.947	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.050	0.950	0.000
T47.2 Stimulant laxatives	0.046	0.954	0.000
T36.3 Macrolides	0.045	0.955	0.000
T42.0 Hydantoin derivatives	0.045	0.955	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.044	0.955	0.000
T50.4 Drugs affecting uric acid metabolism	0.043	0.957	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.043	0.957	0.000
T47.0 Histamine H(2)-receptor antagonists	0.042	0.957	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.042	0.958	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.042	0.958	0.000
T47.7 Emetics	0.042	0.958	0.000
T47.6 Antidiarrhoeal drugs	0.042	0.958	0.000
T47.5 Digestants	0.042	0.958	0.000
T47.4 Other laxatives	0.042	0.958	0.000
T47.3 Saline and osmotic laxatives	0.042	0.958	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.041	0.959	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.041	0.959	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.040	0.960	0.000
T48.5 Anti-common-cold drugs	0.040	0.960	0.000
T48.4 Expectorants	0.040	0.960	0.000
T48.3 Antitussives	0.040	0.960	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.040	0.960	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.040	0.960	0.000
T48.0 Oxytocic drugs	0.040	0.960	0.000
T36.9 Systemic antibiotic, unspecified	0.040	0.960	0.000
T36.8 Other systemic antibiotics	0.040	0.960	0.000
T36.7 Antifungal antibiotics, systemically used	0.040	0.960	0.000
T36.6 Rifamycins	0.040	0.960	0.000
T36.5 Aminoglycosides	0.040	0.960	0.000
T36.4 Tetracyclines	0.040	0.960	0.000
T36.2 Chloramphenicol group	0.040	0.960	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.040	0.960	0.000
T41.5 Therapeutic gases	0.040	0.960	0.000
T41.4 Anaesthetic, unspecified	0.040	0.960	0.000
T41.3 Local anaesthetics	0.040	0.960	0.000
T41.2 Other and unspecified general anaesthetics	0.040	0.960	0.000
T41.1 Intravenous anaesthetics	0.040	0.960	0.000
T41.0 Inhaled anaesthetics	0.040	0.960	0.000
T49.9 Topical agent, unspecified	0.040	0.960	0.000
T49.8 Other topical agents	0.040	0.960	0.000
T49.7 Dental drugs, topically applied	0.040	0.960	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.040	0.960	0.000
T49.5 Ophthalmological drugs and preparations	0.040	0.960	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.040	0.960	0.000
T49.3 Emollients, demulcents and protectants	0.040	0.960	0.000
T49.2 Local astringents and local detergents	0.040	0.960	0.000
T49.1 Antipruritics	0.040	0.960	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.040	0.960	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.039	0.960	0.000
T45.5 Anticoagulants	0.039	0.961	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.038	0.962	0.000
T37.5 Antiviral drugs	0.038	0.962	0.000
T37.4 Anthelminthics	0.038	0.962	0.000
T37.3 Other antiprotozoal drugs	0.038	0.962	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.038	0.962	0.000
T37.1 Antimycobacterial drugs	0.038	0.962	0.000
T37.0 Sulphonamides	0.038	0.962	0.000
T50.7 Analeptics and opioid receptor antagonists	0.038	0.962	0.000
T50.5 Appetite depressants	0.038	0.962	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.038	0.962	0.000
T50.1 Loop [high-ceiling] diuretics	0.038	0.962	0.000
T50.0 Mineralocorticoids and their antagonists	0.038	0.962	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.037	0.963	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.037	0.963	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.035	0.964	0.000
M50.2 Other cervical disk displacement	0.000	0.965	0.035
T50.8 Diagnostic agents	0.034	0.966	0.000
T36.0 Penicillins	0.034	0.966	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.032	0.968	0.000
T45.8 Other primarily systemic and haematological agents	0.032	0.968	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.032	0.968	0.000
T45.6 Fibrinolysis-affecting drugs	0.032	0.968	0.000
T45.4 Iron and its compounds	0.032	0.968	0.000
T45.3 Enzymes, not elsewhere classified	0.032	0.968	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.031	0.969	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.030	0.970	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.029	0.971	0.000
T38.9 Other and unspecified hormone antagonists	0.028	0.971	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.028	0.971	0.000
T38.7 Androgens and anabolic congeners	0.028	0.971	0.000
T38.5 Other oestrogens and progestogens	0.028	0.971	0.000
T38.4 Oral contraceptives	0.028	0.971	0.000
T38.2 Antithyroid drugs	0.028	0.971	0.000
T38.0 Glucocorticoids and synthetic analogues	0.028	0.971	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.029	0.971	0.000
T43.9 Psychotropic drug, unspecified	0.027	0.973	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.027	0.973	0.000
T38.1 Thyroid hormones and substitutes	0.026	0.973	0.000
T45.0 Antiallergic and antiemetic drugs	0.026	0.973	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.026	0.974	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.026	0.974	0.000
T45.2 Vitamins, not elsewhere classified	0.025	0.975	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.023	0.976	0.000
T43.6 Psychostimulants with abuse potential	0.023	0.976	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.023	0.977	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.022	0.978	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.000	0.980	0.020
T43.2 Other and unspecified antidepressants	0.019	0.981	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.019	0.981	0.000
T40.8 Lysergide [LSD]	0.019	0.981	0.000
T40.7 Cannabis (derivatives)	0.019	0.981	0.000
T40.5 Cocaine	0.019	0.981	0.000
T40.3 Methadone	0.019	0.981	0.000
T40.1 Heroin	0.019	0.981	0.000
T40.0 Opium	0.019	0.981	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.017	0.983	0.000
T40.6 Other and unspecified narcotics	0.015	0.984	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.000	0.985	0.015
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.000	0.985	0.015
C31 Malignant neoplasm of accessory sinuses	0.000	0.985	0.015
C33 Malignant neoplasm of trachea	0.000	0.985	0.015
C30 Malignant neoplasm of nasal cavity and middle ear	0.000	0.986	0.014
T40.4 Other synthetic narcotics	0.013	0.987	0.000
R29.6 Tendency to fall, not elsewhere classified	0.000	0.987	0.013
C37 Malignant neoplasm of thymus	0.000	0.987	0.013
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.012	0.987	0.001
C38.4 Pleura	0.000	0.989	0.011
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.000	0.989	0.011
C38.3 Mediastinum, part unspecified	0.000	0.989	0.011
C38.2 Posterior mediastinum	0.000	0.989	0.011
C38.1 Anterior mediastinum	0.000	0.989	0.011
C38.0 Heart	0.000	0.989	0.011
C31.9 Accessory sinus, unspecified	0.000	0.989	0.011
C31.8 Overlapping lesion of accessory sinuses	0.000	0.989	0.011
C31.3 Sphenoidal sinus	0.000	0.989	0.011
C31.2 Frontal sinus	0.000	0.989	0.011
C31.1 Ethmoidal sinus	0.000	0.989	0.011
C31.0 Maxillary sinus	0.000	0.989	0.011
C39.9 Ill-defined sites within the respiratory system	0.000	0.989	0.011
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.000	0.989	0.011
C39.0 Upper respiratory tract, part unspecified	0.000	0.989	0.011
T40.2 Other opioids	0.011	0.989	0.000
C30.1 Middle ear	0.000	0.990	0.010
M13.91 Arthritis, unspecified (Shoulder region)	0.010	0.990	0.000
C30.0 Nasal cavity	0.000	0.991	0.009
L72.0 Epidermal cyst	0.000	0.991	0.009
M50 Cervical disk disorders	0.000	0.991	0.009
M50.3 Other cervical disk degeneration	0.000	0.991	0.009
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.008	0.992	0.000
H61.0 Perichondritis of external ear	0.008	0.992	0.000
C43.3 Malignant melanoma of other and unspecified parts of face	0.000	0.993	0.007
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.007	0.993	0.000
L02 Cutaneous abscess, furuncle and carbuncle	0.007	0.993	0.000
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.006	0.994	0.000
C32 Malignant neoplasm of larynx	0.001	0.994	0.005
M50.8 Other cervical disk disorders	0.000	0.994	0.006
L02.0 Cutaneous abscess, furuncle and carbuncle of face	0.006	0.994	0.000
M77.47 Metatarsalgia-Ankle/Foot	0.005	0.995	0.000
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites	0.005	0.995	0.000
K04.5 Chronic apical periodontitis	0.005	0.995	0.000
F43.1 Posttraumatic stress disorder	0.005	0.995	0.000
F43.2 Adjustment disorders	0.005	0.995	0.000
M50.9 Cervical disk disorder, unspecified	0.000	0.995	0.005
M50.0 Cervical disk disorder with myelopathy	0.000	0.995	0.005
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.005	0.995	0.000
N32.9 Bladder disorder, unspecified	0.005	0.995	0.000
C32.8 Overlapping lesion of larynx	0.001	0.995	0.004
C32.3 Laryngeal cartilage	0.001	0.995	0.004
C32.2 Subglottis	0.001	0.995	0.004
F43 Reaction to severe stress, and adjustment disorders	0.005	0.995	0.000
M50.1 Cervical disk disorder with radiculopathy	0.000	0.996	0.004
D03.3 Melanoma in situ of other and unspecified parts of face	0.004	0.996	0.000
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.004	0.996	0.000
K04.6 Periapical abscess with sinus	0.004	0.996	0.000
N85.8 Other specified noninflammatory disorders of uterus	0.004	0.996	0.000
K04.7 Periapical abscess without sinus	0.004	0.996	0.000
F43.0 Acute stress reaction	0.004	0.996	0.000
H61 Other disorders of external ear	0.004	0.996	0.000
K04 Diseases of pulp and periapical tissues	0.004	0.996	0.000
S02.80 Fractures of other skull and facial bones (closed)	0.004	0.996	0.000
F43.8 Other reactions to severe stress	0.003	0.996	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.003	0.996	0.000
K04.0 Pulpitis	0.003	0.997	0.000
T78.4 Allergy, unspecified	0.003	0.997	0.000
H61.2 Impacted cerumen	0.003	0.997	0.000
C32.0 Glottis	0.000	0.997	0.003
Y85.0 Sequelae of motor-vehicle accident	0.000	0.997	0.003
B37.9 Candidiasis, unspecified	0.003	0.997	0.000
H61.3 Acquired stenosis of external ear canal	0.003	0.997	0.000
C32.1 Supraglottis	0.001	0.997	0.002
F43.9 Reaction to severe stress, unspecified	0.003	0.997	0.000
H61.9 Disorder of external ear, unspecified	0.003	0.997	0.000
X63.0 Home	0.003	0.997	0.000
C32.9 Larynx, unspecified	0.001	0.997	0.002
T31.0 Burns involving less than 10% of body surface	0.000	0.997	0.003
S32.50 Fracture of pubis (closed)	0.000	0.997	0.003
K04.3 Abnormal hard tissue formation in pulp	0.003	0.997	0.000
K04.2 Pulp degeneration	0.003	0.997	0.000
K04.1 Necrosis of pulp	0.003	0.997	0.000
S02.8 Fractures of other skull and facial bones	0.003	0.997	0.000
S02.4 Fracture of malar and maxillary bones	0.003	0.997	0.000
Y45.1 Salicylates	0.000	0.997	0.003
E07.9 Disorder of thyroid, unspecified	0.000	0.997	0.003
M25.57 Pain in joint (Ankle and foot)	0.000	0.997	0.003
D80.1 Nonfamilial hypogammaglobulinaemia	0.003	0.997	0.000
K04.9 Other and unspecified diseases of pulp and periapical tissues	0.003	0.997	0.000
S02.60 Fracture of mandible (closed)	0.003	0.997	0.000
H35.3 Degeneration of macula and posterior pole	0.003	0.997	0.000
K29.0 Acute haemorrhagic gastritis	0.000	0.997	0.003
R01.1 Cardiac murmur, unspecified	0.000	0.997	0.003
S01.8 Open wound of other parts of head	0.000	0.997	0.003
Z09.8 Follow-up examination after other treatment for other conditions	0.003	0.997	0.000
M48.86 Other specified spondylopathies (Lumbar region)	0.002	0.997	0.000
M77.4 Metatarsalgia	0.002	0.997	0.000
R61.9 Hyperhidrosis, unspecified	0.000	0.997	0.003
S02.6 Fracture of mandible	0.002	0.998	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000
M11.26 Other chondrocalcinosis (Lower leg)	0.000	0.998	0.002
D03.7 Melanoma in situ of lower limb, including hip	0.002	0.998	0.000
S02.81 Fractures of other skull and facial bones (open)	0.002	0.998	0.000
S02 Fracture of skull and facial bones	0.002	0.998	0.000
S02.41 Fracture of malar and maxillary bones (open)	0.002	0.998	0.000
H83.0 Labyrinthitis	0.002	0.998	0.000
G25.2 Other specified forms of tremor	0.002	0.998	0.000
M48.02 Spinal stenosis (Cervical region)	0.002	0.998	0.000
M48.8 Other specified spondylopathies	0.002	0.998	0.000
D03 Melanoma in situ	0.002	0.998	0.000
H33.2 Serous retinal detachment	0.000	0.998	0.002
W18.3 Sports and athletics area	0.002	0.998	0.000
C43.4 Malignant melanoma of scalp and neck	0.000	0.998	0.002
G25 Other extrapyramidal and movement disorders	0.002	0.998	0.000
S02.0 Fracture of vault of skull	0.002	0.998	0.000
Z56.3 Stressful work schedule	0.002	0.998	0.000
K83.1 Obstruction of bile duct	0.000	0.998	0.002
M77.49 Metatarsalgia-Site unspec	0.002	0.998	0.000
M77.48 Metatarsalgia-Other	0.002	0.998	0.000
M77.46 Metatarsalgia-Lower Leg	0.002	0.998	0.000
M77.45 Metatarsalgia-Pelvic/Thigh	0.002	0.998	0.000
M77.44 Metatarsalgia-Hand	0.002	0.998	0.000
M77.43 Metatarsalgia-Forearm	0.002	0.998	0.000
M77.42 Metatarsalgia-Upper arm	0.002	0.998	0.000
M77.41 Metatarsalgia-Shldr region	0.002	0.998	0.000
M77.40 Metatarsalgia-Mult sites	0.002	0.998	0.000
G25.9 Extrapyramidal and movement disorder, unspecified	0.002	0.998	0.000
S02.61 Fracture of mandible (open)	0.002	0.998	0.000
G25.8 Other specified extrapyramidal and movement disorders	0.002	0.998	0.000
M48.0 Spinal stenosis	0.002	0.998	0.000
M48.5 Collapsed vertebra, not elsewhere classified	0.002	0.998	0.000
X63.9 Unspecified place	0.002	0.998	0.000
X63.8 Other specified place	0.002	0.998	0.000
X63.7 Farm	0.002	0.998	0.000
X63.6 Industrial and construction area	0.002	0.998	0.000
X63.5 Trade and service area	0.002	0.998	0.000
X63.4 Street and highway	0.002	0.998	0.000
X63.3 Sports and athletics area	0.002	0.998	0.000
X63.2 School, other institution and public administrative area	0.002	0.998	0.000
X63.1 Residential institution	0.002	0.998	0.000
M48.09 Spinal stenosis (Site unspecified)	0.002	0.998	0.000
M48.50 Collapsed vertebra, not elsewhere classified (Multiple sites in spine)	0.002	0.998	0.000
X68.9 Unspecified place	0.002	0.998	0.000
M48 Other spondylopathies	0.002	0.998	0.000
S02.00 Fracture of vault of skull (closed)	0.002	0.998	0.000
D03.4 Melanoma in situ of scalp and neck	0.002	0.998	0.000
S02.5 Fracture of tooth	0.002	0.998	0.000
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)	0.002	0.998	0.000
D03.1 Melanoma in situ of eyelid, including canthus	0.002	0.998	0.000
H61.1 Non-infective disorders of pinna	0.002	0.998	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.002	0.998	0.000
M48.07 Spinal stenosis (Lumbosacral region)	0.002	0.998	0.000
F42.2 Mixed obsessional thoughts and acts	0.002	0.998	0.000
G25.5 Other chorea	0.002	0.998	0.000
L43.8 Other lichen planus	0.002	0.998	0.000
X60-X84 Intentional self-harm	0.002	0.998	0.000
I98.2 Oesophageal varices in diseases classified elsewhere	0.000	0.998	0.002
N50.0 Atrophy of testis	0.002	0.998	0.000
R19.5 Other fecal abnormalities	0.000	0.998	0.002
S02.9 Fracture of skull and facial bones, part unspecified	0.002	0.998	0.000
R09.1 Pleurisy	0.002	0.998	0.000
Y85 Sequelae of transport accidents	0.000	0.998	0.002
M48.89 Other specified spondylopathies (Site unspecified)	0.002	0.998	0.000
M48.88 Other specified spondylopathies (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M48.87 Other specified spondylopathies (Lumbosacral region)	0.002	0.998	0.000
M48.85 Other specified spondylopathies (Thoracolumbar region)	0.002	0.998	0.000
M48.84 Other specified spondylopathies (Thoracic region)	0.002	0.998	0.000
M48.83 Other specified spondylopathies (Cervicothoracic region)	0.002	0.998	0.000
M48.82 Other specified spondylopathies (Cervical region)	0.002	0.998	0.000
M48.81 Other specified spondylopathies (Occipito-atlanto-axial region)	0.002	0.998	0.000
M48.80 Other specified spondylopathies (Multiple sites in spine)	0.002	0.998	0.000
D03.9 Melanoma in situ, unspecified	0.002	0.998	0.000
D03.8 Melanoma in situ of other sites	0.002	0.998	0.000
D03.0 Melanoma in situ of lip	0.002	0.998	0.000
G25.1 Drug-induced tremor	0.002	0.998	0.000
H61.8 Other specified disorders of external ear	0.002	0.998	0.000
X78.2 School, other institution and public administrative area	0.002	0.998	0.000
Z56.0 Unemployment, unspecified	0.002	0.998	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.002	0.998	0.000
S02.3 Fracture of orbital floor	0.002	0.998	0.000
X70.2 School, other institution and public administrative area	0.002	0.998	0.000
Z64.0 Problems related to unwanted pregnancy	0.002	0.998	0.000
Z56 Problems related to employment and unemployment	0.002	0.998	0.000
F44.5 Dissociative convulsions	0.002	0.998	0.000
M48.9 Spondylopathy, unspecified	0.002	0.998	0.000
Z63.4 Disappearance and death of family member	0.002	0.998	0.000
F42 Obsessive-compulsive disorder	0.002	0.998	0.000
G25.6 Drug-induced tics and other tics of organic origin	0.002	0.998	0.000
G25.4 Drug-induced chorea	0.002	0.998	0.000
G25.3 Myoclonus	0.002	0.998	0.000
X78 Intentional self-harm by sharp object	0.002	0.998	0.000
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M65.84 Other synovitis and tenosynovitis (Hand)	0.002	0.998	0.000
K04.4 Acute apical periodontitis of pulpal origin	0.001	0.998	0.001
S02.01 Fracture of vault of skull (open)	0.002	0.998	0.000
Y85.9 Sequelae of other and unspecified transport accidents	0.000	0.998	0.002
D86.0 Sarcoidosis of lung	0.000	0.998	0.002
F81.9 Developmental disorder of scholastic skills, unspecified	0.000	0.998	0.002
S02.7 Multiple fractures involving skull and facial bones	0.002	0.998	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.002	0.998	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.002	0.998	0.000
F42.0 Predominantly obsessional thoughts or ruminations	0.002	0.998	0.000
G25.0 Essential tremor	0.002	0.998	0.000
M48.99 Spondylopathy, unspecified (Site unspecified)	0.002	0.998	0.000
O32.0 Maternal care for unstable lie	0.002	0.998	0.000
M48.05 Spinal stenosis (Thoracolumbar region)	0.002	0.998	0.000
M48.03 Spinal stenosis (Cervicothoracic region)	0.002	0.998	0.000
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.002	0.998	0.000
T31 Burns classified according to extent of body surface involved	0.000	0.998	0.002
M48.59 Collapsed vertebra, not elsewhere classified (Site unspecified)	0.002	0.998	0.000
M48.58 Collapsed vertebra, not elsewhere classified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M48.57 Collapsed vertebra, not elsewhere classified (Lumbosacral region)	0.002	0.998	0.000
M48.53 Collapsed vertebra, not elsewhere classified (Cervicothoracic region)	0.002	0.998	0.000
M48.52 Collapsed vertebra, not elsewhere classified (Cervical region)	0.002	0.998	0.000
M48.51 Collapsed vertebra, not elsewhere classified (Occipito-atlanto-axial region)	0.002	0.998	0.000
X63.99 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system; Unspecified place ;During unspecified activity	0.001	0.998	0.000
D80 Immunodeficiency with predominantly antibody defects	0.002	0.998	0.000
M48.4 Fatigue fracture of vertebra	0.002	0.998	0.000
M48.3 Traumatic spondylopathy	0.002	0.998	0.000
M48.2 Kissing spine	0.002	0.998	0.000
M48.1 Ankylosing hyperostosis [Forestier]	0.002	0.998	0.000
R06.5 Mouth breathing	0.002	0.998	0.000
F44 Dissociative [conversion] disorders	0.002	0.998	0.000
X84 Intentional self-harm by unspecified means	0.002	0.998	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.002	0.998	0.000
S02.51 Fracture of tooth (open)	0.002	0.998	0.000
S02.50 Fracture of tooth (closed)	0.002	0.998	0.000
X67.9 Unspecified place	0.002	0.998	0.000
X68.8 Other specified place	0.001	0.998	0.000
X68.7 Farm	0.001	0.998	0.000
X68.6 Industrial and construction area	0.001	0.998	0.000
X68.5 Trade and service area	0.001	0.998	0.000
X68.4 Street and highway	0.001	0.998	0.000
X68.3 Sports and athletics area	0.001	0.998	0.000
X68.2 School, other institution and public administrative area	0.001	0.998	0.000
X68.1 Residential institution	0.001	0.998	0.000
X68.0 Home	0.001	0.998	0.000
Z02.8 Other examinations for administrative purposes	0.002	0.998	0.000
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.001	0.998	0.000
F17.2 Dependence syndrome	0.002	0.998	0.000
F42.9 Obsessive-compulsive disorder, unspecified	0.002	0.998	0.000
G90.3 Multisystem degeneration	0.000	0.998	0.002
X65.8 Other specified place	0.002	0.998	0.000
X69.0 Home	0.002	0.998	0.000
X83 Intentional self-harm by other specified means	0.002	0.998	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.002	0.998	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.002	0.998	0.000
X80 Intentional self-harm by jumping from a high place	0.002	0.998	0.000
X79 Intentional self-harm by blunt object	0.002	0.998	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.002	0.998	0.000
X76 Intentional self-harm by smoke, fire and flames	0.002	0.998	0.000
X75 Intentional self-harm by explosive material	0.002	0.998	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.002	0.998	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.002	0.998	0.000
X72 Intentional self-harm by handgun discharge	0.002	0.998	0.000
X71 Intentional self-harm by drowning and submersion	0.002	0.998	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.002	0.998	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
S02.31 Fracture of orbital floor (open)	0.001	0.998	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.002	0.998	0.000
X70.8 Other specified place	0.001	0.998	0.000
X70.9 Unspecified place	0.001	0.998	0.000
X70.7 Farm	0.001	0.998	0.000
X70.6 Industrial and construction area	0.001	0.998	0.000
X70.5 Trade and service area	0.001	0.998	0.000
X70.4 Street and highway	0.001	0.998	0.000
X70.3 Sports and athletics area	0.001	0.998	0.000
X70.1 Residential institution	0.001	0.998	0.000
X70.0 Home	0.001	0.998	0.000
Z56.7 Other and unspecified problems related to employment	0.001	0.998	0.000
Z56.5 Uncongenial work	0.001	0.998	0.000
Z56.4 Discord with boss and workmates	0.001	0.998	0.000
Z56.2 Threat of job loss	0.001	0.998	0.000
Z56.1 Change of job	0.001	0.998	0.000
M48.04 Spinal stenosis (Thoracic region)	0.001	0.998	0.000
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.001	0.998	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
Z64 Problems related to certain psychosocial circumstances	0.002	0.998	0.000
M48.55 Collapsed vertebra, not elsewhere classified (Thoracolumbar region)	0.001	0.998	0.000
M48.98 Spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.001	0.998	0.000
M48.97 Spondylopathy, unspecified (Lumbosacral region)	0.001	0.998	0.000
M48.96 Spondylopathy, unspecified (Lumbar region)	0.001	0.998	0.000
M48.95 Spondylopathy, unspecified (Thoracolumbar region)	0.001	0.998	0.000
M48.94 Spondylopathy, unspecified (Thoracic region)	0.001	0.998	0.000
M48.93 Spondylopathy, unspecified (Cervicothoracic region)	0.001	0.998	0.000
M48.92 Spondylopathy, unspecified (Cervical region)	0.001	0.998	0.000
M48.91 Spondylopathy, unspecified (Occipito-atlanto-axial region)	0.001	0.998	0.000
M48.90 Spondylopathy, unspecified (Multiple sites in spine)	0.001	0.998	0.000
F41.1 Generalised anxiety disorder	0.000	0.998	0.002
F42.8 Other obsessive-compulsive disorders	0.001	0.998	0.000
F42.1 Predominantly compulsive acts [obsessional rituals]	0.001	0.998	0.000
I98.3 Oesophageal varices with bleeding in diseases classified elsewhere	0.000	0.998	0.002
S46.2 Injury of muscle and tendon of other parts of biceps	0.002	0.998	0.000
C43 Malignant melanoma of skin	0.000	0.998	0.002
F44.9 Dissociative [conversion] disorder, unspecified	0.001	0.998	0.000
X78.9 Unspecified place	0.001	0.998	0.000
X78.8 Other specified place	0.001	0.998	0.000
X78.7 Farm	0.001	0.998	0.000
X78.6 Industrial and construction area	0.001	0.998	0.000
X78.5 Trade and service area	0.001	0.998	0.000
X78.4 Street and highway	0.001	0.998	0.000
X78.3 Sports and athletics area	0.001	0.998	0.000
X78.1 Residential institution	0.001	0.998	0.000
R29 Other symptoms and signs involving the nervous and musculoskeletal systems	0.000	0.998	0.002
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.001	0.998	0.000
S02.2 Fracture of nasal bones	0.002	0.998	0.000
Z59 Problems related to housing and economic circumstances	0.002	0.998	0.000
M48.00 Spinal stenosis (Multiple sites in spine)	0.001	0.998	0.000
S02.71 Multiple fractures involving skull and facial bones (open)	0.001	0.998	0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.001	0.998	0.000
L04.1 Acute lymphadenitis of trunk	0.001	0.998	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.002	0.998	0.000
X65.9 Unspecified place	0.001	0.998	0.000
X65.0 Home	0.001	0.998	0.000
X65.7 Farm	0.001	0.998	0.000
X65.6 Industrial and construction area	0.001	0.998	0.000
X65.5 Trade and service area	0.001	0.998	0.000
X65.4 Street and highway	0.001	0.998	0.000
X65.3 Sports and athletics area	0.001	0.998	0.000
X65.2 School, other institution and public administrative area	0.001	0.998	0.000
X65.1 Residential institution	0.001	0.998	0.000
X67.8 Other specified place	0.001	0.998	0.000
X67.7 Farm	0.001	0.998	0.000
X67.6 Industrial and construction area	0.001	0.998	0.000
X67.5 Trade and service area	0.001	0.998	0.000
X67.4 Street and highway	0.001	0.998	0.000
X67.3 Sports and athletics area	0.001	0.998	0.000
X67.2 School, other institution and public administrative area	0.001	0.998	0.000
X67.1 Residential institution	0.001	0.998	0.000
X67.0 Home	0.001	0.998	0.000
Z56.6 Other physical and mental strain related to work	0.001	0.998	0.000
Z59.1 Inadequate housing	0.001	0.998	0.000
S82.10 Fracture of upper end of tibia (closed)	0.002	0.998	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.001	0.998	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.001	0.998	0.000
S32.5 Fracture of pubis	0.000	0.998	0.001
T31.1 Burns involving 10-19% of body surface	0.000	0.998	0.001
X84.9 Unspecified place	0.001	0.998	0.000
Z59.0 Homelessness	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations